| Literature DB >> 35761338 |
Abstract
BACKGROUND: Although the cardiovascular health and quality of life (QoL) of stroke survivors have been previously studied, no study has investigated the correlation between cardiovascular health and QoL. This study aimed to investigate whether there would be a difference in the quality of life (QoL) in this population depending on the degree of cardiovascular health.Entities:
Keywords: Cardiovascular health; Ischemic heart disease; Quality of life; Stroke
Mesh:
Year: 2022 PMID: 35761338 PMCID: PMC9235080 DOI: 10.1186/s12955-022-02008-7
Source DB: PubMed Journal: Health Qual Life Outcomes ISSN: 1477-7525 Impact factor: 3.077
Characteristic of stroke survivors
| 2013–2014 | 2015–2016 | 2017–2018 | ||
|---|---|---|---|---|
| N | 145 | 198 | 234 | |
| Age (years) | 63.23 ± 1.12 | 66.43 ± 0.87 | 66.95 ± 0.84 | 0.0308 |
| Sex, female (%) | 27.0 (3.56) | 39.7 (3.85) | 43.5 (3.90) | 0.0109 |
| Marital status, married (%) | 95.2 (2.31) | 97.5 (1.73) | 95.7 (1.51) | 0.6611 |
| Education level | 0.7458 | |||
| > 12 | 89.2 (3.30) | 90.7 (2.51) | 87.9 (2.43) | |
| ≤ 12 | 10.8 (3.30) | 9.3 (2.51) | 12.1 (2.43) | |
| Residential area, urban (%) | 74.4 (4.99) | 83.3 (3.35) | 81.9 (3.11) | 0.2640 |
| Household income (%) | 0.5503 | |||
| 1Q | 40.9 (5.34) | 41.0 (4.50) | 32.7 (3.58) | |
| 2Q | 21.4 (4.13) | 20.5 (3.04) | 23.1 (3.21) | |
| 3Q | 15.3 (3.21) | 16.5 (2.80) | 23.1 (3.54) | |
| 4Q | 22.4 (4.38) | 22.0 (3.43) | 21.1 (3.20) | |
| Economic activity, yes (%) | 42.9 (4.94) | 34.7 (4.27) | 35.4 (3.72) | 0.3921 |
| Time since stroke onset (years) | 8.77 ± 0.57 | 9.16 ± 0.54 | 9.53 ± 0.63 | 0.1536 |
| Current drinking, yes (%) | 18.2 (4.08) | 18.1 (2.85) | 17.1 (3.12) | 0.9627 |
Values are weighted mean ± SE or weighted percentage (SE), unless otherwise indicated
*p-value by ANOVA or Rao–Scott chi-square test, as appropriate
Prevalence of cardiovascular health metrics among individuals with a history of stroke
| 2013–2014 | 2015–2016 | 2017–2018 | |||||
|---|---|---|---|---|---|---|---|
| n | Prevalence (%, 95% CI) | n | Prevalence (%, 95% CI) | n | Prevalence (%, 95% CI) | ||
| Current (0) | 22 | 11.10 (6.83–17.54) | 35 | 14.02 (9.21–20.78) | 39 | 14.23 (9.73–20.35) | 0.6719 |
| Quit smoking < 12 months (1) | 2 | 0.53 (0.10–2.62) | 4 | 2.19 (1.06–4.44) | 3 | 1.05 (0.24–4.48) | 0.1736 |
| Never or quit smoking ≥ 12 months (2) | 121 | 88.39 (81.92–92.75) | 159 | 83.43 (76.59–88.57) | 192 | 84.56 (78.20–89.32) | 0.4367 |
| None (0) | 39 | 25.19 (18.01–34.05) | 59 | 28.39 (22.48–35.15) | 78 | 29.10 (22.09–37.26) | 0.7821 |
| Intermediate (1) | 93 | 64.33 (54.36–73.20) | 127 | 65.74 (58.34–72.44) | 148 | 66.81 (58.72–74.03) | 0.9255 |
| Ideal (2) | 13 | 9.61 (5.46–16.35) | 12 | 5.52 (2.90–10.27) | 8 | 3.73 (1.67–8.13) | 0.1239 |
| ≥ 25 (0) | 58 | 44.82 (35.81–54.19) | 90 | 42.14 (34.61–50.05) | 94 | 40.78 (33.88–48.06) | 0.7978 |
| 23–24.9 (1) | 30 | 16.83 (11.30–24.33) | 47 | 25.61 (18.63–34.11) | 66 | 28.88 (22.37–36.39) | 0.0615 |
| < 23 (2) | 57 | 38.13 (29.57–47.49) | 61 | 32.05 (24.73–40.38) | 74 | 30.08 (23.42–37.71) | 0.3778 |
| Non-adherent (0) | 72 | 45.27 (35.49–55.42) | 81 | 41.68 (33.94–49.85) | 81 | 36.57 (28.90–45.00) | 0.3997 |
| Slightly adherent (1) | 63 | 48.07 (38.10–58.19) | 101 | 51.06 (43.26–58.82) | 126 | 52.54 (44.40–60.55) | 0.7989 |
| Highly adherent (2) | 10 | 5.15 (2.65–9.79) | 16 | 5.99 (3.47–10.16) | 27 | 9.00 (5.75–13.81) | 0.2910 |
| ≥ 240 (0) | 4 | 3.02 (0.90–9.58) | 9 | 4.82 (2.22–10.14) | 17 | 7.12 (4.12–12.02) | 0.3808 |
| 200–239 (1) | 31 | 21.75 (14.77–30.84) | 42 | 19.34 (13.87–26.30) | 28 | 10.40 (6.64–15.93) | 0.0226 |
| < 200 (2) | 110 | 75.33 (65.68–82.98) | 147 | 75.48 (67.99–81.70) | 189 | 82.09 (75.33–87.31) | 0.2745 |
| ≥ 140/ ≥ 90 (0) | 37 | 24.33 (17.39–32.94) | 52 | 26.15 (18.84–35.06) | 66 | 31.77 (24.51–40.04) | 0.3801 |
| 120–139/80–89 (1) | 60 | 41.28 (31.96–51.27) | 84 | 42.31 (34.56–50.45) | 102 | 40.63 (33.50–48.17) | 0.9540 |
| < 120/ < 80 (2) | 48 | 34.22 (26.08–43.41) | 62 | 31.45 (24.69–39.10) | 66 | 27.47 (20.53–35.69) | 0.5160 |
| ≥ 126 (0) | 26 | 18.36 (11.53–27.95) | 40 | 20.44 (14.23–28.45) | 66 | 30.43 (23.28–38.67) | 0.0661 |
| 100–125 (1) | 54 | 33.02 (24.92–42.27) | 71 | 35.65 (27.33–44.94) | 84 | 32.92 (25.87–40.84) | 0.8798 |
| < 100 (2) | 65 | 48.57 (39.21–58.03) | 87 | 43.62 (35.63–51.96) | 84 | 36.47 (28.97–44.68) | 0.1532 |
| Poor CV health score (0–7) | 51 | 33.57 (25.22–43.10) | 86 | 44.01 (35.70–52.67) | 95 | 44.67 (36.22–53.43) | 0.1778 |
| Intermediate CV health score (8–10) | 80 | 57.70 (48.85–66.08) | 97 | 47.49 (38.75–56.38) | 120 | 46.39 (38.66–54.29) | 0.1376 |
| Ideal CV health score (11–14) | 14 | 8.00 (4.21–14.70) | 15 | 7.72 (4.59–12.70) | 19 | 8.14 (4.72–13.71) | 0.9898 |
Adjusted for age and sex
*p-value by logistic regression (adjusted for age and sex)
Fig. 1EQ-5D index score among persons with a history of stroke. The EQ-5D index score was calculated as least mean square after sex and age were adjusted, and p = 0.0015 in 2013–2014, p = 0.0040 in 2015–2016, and p < 0.0001 in 2017–2018. EQ-5D, five dimentional European Quality of Life Questionnaire
Prevalence of having problems in each EQ-5D dimension among persons with a history of stroke (n = 577)
| Poor group (0–7) | Intermediate group (8–10) | Ideal group (11–14) | |||
|---|---|---|---|---|---|
| Mobility | Prevalence (%, 95% CI) | 49.0 (33.3–64.9) | 55.7 (43.3–67.4) | 29.3 (10.3–60.0) | 0.2492 |
| Self-care | Prevalence (%, 95% CI) | 35.1 (21.1–52.3) | 37.3 (26.7–49.2) | 18.2 (5.7–45.2) | 0.3755 |
| Usual activities | Prevalence (%, 95% CI) | 47.1 (31.5–63.4) | 44.1 (32.9–56.0) | 18.5 (5.8–45.4) | 0.1605 |
| Pain/discomfort | Prevalence (%, 95% CI) | 65.4 (48.5–79.1) | 52.0 (40.2–63.6) | 26.9 (9.1–57.5) | 0.1000 |
| Anxiety/depression | Prevalence (%, 95% CI) | 38.9 (24.1–56.1) | 29.0 (18.2–42.9) | 9.7 (2.1–35.5) | 0.1179 |
| Mobility | Prevalence (%, 95% CI) | 61.9 (48.4–73.7) | 48.3 (37.0–59.7) | 24.4 (9.7–49.1) | 0.0371 |
| Self-care | Prevalence (%, 95% CI) | 35.5 (23.6–49.4) | 22.6 (15.1–32.4) | 13.9 (4.2–37.3) | 0.1202 |
| Usual activities | Prevalence (%, 95% CI) | 51.4 (38.4–64.1) | 38.5 (28.3–49.8) | 16.1 (5.5–38.7) | 0.0322 |
| Pain/discomfort | Prevalence (%, 95% CI) | 53.5 (40.8–65.8) | 45.4 (34.4–56.9) | 18.0 (5.9–43.3) | 0.0420 |
| Anxiety/depression | Prevalence (%, 95% CI) | 35.3 (24.0–48.5) | 24.4 (16.9–33.8) | 21.9 (7.8–48.2) | 0.1914 |
| Mobility | Prevalence (%, 95% CI) | 41.7 (30.2–54.1) | 33.3 (22.5–46.3) | 10.9 (3.2–31.2) | 0.0486 |
| Self-care | Prevalence (%, 95% CI) | 20.3 (11.3–33.6) | 10.4 (5.9–17.6) | 12.1 (3.6–33.3) | 0.1818 |
| Usual activities | Prevalence (%, 95% CI) | 35.1 (23.7–48.5) | 20.5 (13.3–30.2) | 17.7 (6.1–41.5) | 0.0888 |
| Pain/discomfort | Prevalence (%, 95% CI) | 45.6 (33.9–57.9) | 41.7 (30.7–53.6) | 29.6 (12.3–55.8) | 0.5458 |
| Anxiety/depression | Prevalence (%, 95% CI) | 16.4 (9.6–26.7) | 10.9 (5.5–20.2) | 4.1 (0.7–20.7) | 0.2469 |
Adjusted for age and sex